ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $324,000 | -16.7% | 6,300 | 0.0% | 0.08% | +20.6% |
| Q4 2019 | $389,000 | -8.0% | 6,300 | -10.6% | 0.06% | -10.0% |
| Q3 2019 | $423,000 | -48.2% | 7,044 | -27.1% | 0.07% | -44.4% |
| Q2 2019 | $816,000 | -19.7% | 9,667 | -9.1% | 0.13% | -20.3% |
| Q1 2019 | $1,016,000 | -51.5% | 10,637 | -64.1% | 0.16% | -55.6% |
| Q4 2018 | $2,096,000 | -7.1% | 29,594 | +12.1% | 0.36% | +21.9% |
| Q3 2018 | $2,256,000 | +3.1% | 26,393 | +39.8% | 0.29% | -4.3% |
| Q2 2018 | $2,188,000 | +180.2% | 18,879 | +95.6% | 0.30% | +158.5% |
| Q1 2018 | $781,000 | -46.6% | 9,652 | -66.4% | 0.12% | +61.6% |
| Q4 2014 | $1,462,000 | – | 28,759 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |